Endometriosis and Migraine
PDF
Cite
Share
Request
Review
P: 256-262
April 2023

Endometriosis and Migraine

GMJ 2023;34(2):256-262
1. Neuropsychiatry Center, Gazi University, Besevler, Ankara, Turkiye
2. Department of Neurology and Algology, Neuroscience and Neurotechnology Center (NÖROM), Gazi University Faculty of Medicine, Besevler, Ankara, Turkiye
No information available.
No information available
Received Date: 02.02.2023
Accepted Date: 07.02.2023
PDF
Cite
Share
Request

ABSTRACT

Endometriosis and migraine are two of the most disabling pain disorders in the world, effecting millions of people and causing a big socioeconomical burden. Endometriosis is defined as the presence of endometrium like tissue outside of uterus. It is a chronic, hormone dependent, neuroinflammatory disorder, presented with pain and infertility as its two main symptoms. Migraine is characterized by episodic headaches accompanied by nausea, vomiting and photo phonophobia. Even though both disorders have been studied extensively, our understanding of their pathophysiology and treatment are limited. There are population based and geneti c studies showing their co morbidity. Early menarche and late menopause are well known risk factors for both diseases. Migraine is seen three fold more in women than men. The main strategy for the medical treatment of endometriosis related pain is estrogen suppression. In this review, we approached endometriosis and migraine co morbidity by discussing the hormone inflamation relationship, neurovascular structures and the modifications in the central and peripheral nervous system.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House